Ashfaq v. Anderson

603 F. Supp. 2d 936, 2009 U.S. Dist. LEXIS 25243, 2009 WL 736074
CourtDistrict Court, N.D. Texas
DecidedMarch 16, 2009
Docket3:08-cv-01232
StatusPublished

This text of 603 F. Supp. 2d 936 (Ashfaq v. Anderson) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ashfaq v. Anderson, 603 F. Supp. 2d 936, 2009 U.S. Dist. LEXIS 25243, 2009 WL 736074 (N.D. Tex. 2009).

Opinion

MEMORANDUM ORDER

JANE J. BOYLE, District Judge.

Plaintiff Raheela Ashfaq, M.D. (hereinafter, “Dr. Ashfaq”) brings this action against Defendant Ron Anderson, M.D. (hereinafter, “Dr. Anderson”), alleging violations of the Civil Rights Act, 42 U.S.C. § 1983, and various state law causes of action. Before the Court is Dr. Anderson’s Motion to Dismiss (doc. 10), on the basis of qualified immunity. Having considered the motion to dismiss and the briefing of the parties, the Court is of the opinion that the Motion should be and hereby is GRANTED.

I.

BACKGROUND

This case involves medical professionals working for the University of Texas Southwestern Medical Center (hereinafter, “UTSW”) and Parkland Health and Hospital System (hereinafter, “Parkland”). (Compl.) UTSW and Parkland entered into a Master Services Agreement (hereinafter, the “MSA”) whereby UTSW physicians provide medical, administrative, and educational services at the Parkland facilities. {Id. at ¶ 49.)

Dr. Ashfaq is employed as a professor of pathology at UTSW. {Id. at ¶ 8.) Throughout her tenure, Dr. Ashfaq has served in various positions of leadership and supervision at UTSW and its affiliated hospitals, including Parkland. {Id. at ¶ 9.) Most recently, Dr. Ashfaq held appointments as the director of the Cytopathology Fellowship Program at UTSW and the Cytopa-thology Laboratory and the Fine Needle Aspiration Clinics at Parkland. {Id.) Her removal from these appointments is the subject of this suit.

In September 2007, Parkland’s lead commodity buyer asked Dr. Ashfaq to sit on a Parkland selection committee and evaluate bids being taken from companies seeking to supply Parkland with equipment and supplies for a liquid-based pap test. {Id. at ¶¶ 17, 32.) Upon agreeing to participate on the committee, Dr. Ashfaq was asked to a sign a Non-Disclosure Agreement and Conflict of Interest Statement. {Id. at ¶¶ 17-8.) She merely skimmed this document before signing and assenting to its terms. {Id. at ¶ 17.)

*939 While sitting on the selection committee, Dr. Ashfaq scored a proposal submitted by Hologic/Cytyc. (Id. at ¶ 21.) When scoring this proposal, Dr. Ashfaq failed to disclose that she had previously served on Hologic/Cytyc’s speakers bureau and received honoraria from Hologic/Cytyc. (Id. at 21-3.) On November 19, 2007, Dr. Ash-faq attended a lecture on Parkland’s ethics policies and procedures. (Id. at ¶ 22.) After attending this lecture, Dr. Ashfaq was concerned about her prior failure to disclose her history with Hologic/Cytyc. (Id. at ¶ 23.) Accordingly, she contacted Nancy Merritt (hereinafter, “Merritt”), Parkland’s Compliance Officer, and Debbie Perrault, the Lab Director, to voice her concerns and ask that her scores on the Hologic/Cytyc proposal not be counted. (Id. at ¶¶23^.) Her scores were not counted, and Hologic/Cytyc was never awarded the contract. (Id. at ¶ 24.)

Nevertheless, Merritt and others allegedly initiated an investigation into Dr. Ashfaq’s conflicts of interest, and informed Michael Silhol (hereinafter, “Silhol”), Parkland’s general counsel. (Id. at ¶¶ 28-30.) In late January 2008, Silhol determined that Dr. Ashfaq should be removed from her appointments at Parkland due to the appearance of impropriety brought about by Dr. Ashfaq’s conflicts of interest. (Id. at ¶ 31.) Silhol drafted a letter to this effect, and forwarded it to Dr. Anderson, (id.), Parkland’s President and Chief Executive Officer, (Id. at ¶ 6), for his signature. Dr. Anderson signed the letter and sent it to the Executive Vice President for Business Affairs at UTSW. (Id.) In short, Dr. Anderson’s letter stated that Dr. Ashfaq failed to abide by Parkland’s Code of Conduct and Ethics, (id.), and demanded that Dr. Ashfaq be replaced with another UTSW physician, (Id. at ¶ 32). Specifically, the letter contends that Dr. Ashfaq had a “clear and very serious conflict of interest that [she] failed to disclose!,]” (id.), bringing “disrepute to Parkland’s activities and reputation!,]” (Id. at ¶ 33). In response to the letter, doctor Errol Fried-berg (hereinafter, “Dr. Friedberg”), the chair of the pathology department at UTSW, removed Dr. Ashfaq from her appointments as Director of the Pathology Fellowship Program at UTSW and Director of the Cytopathology Laboratory and Fine Needle Aspiration Clinics at Parkland. (Id. at ¶ 38.) Dr. Friedberg further admonished Dr. Ashfaq to restrict her professional activities to locations outside of Parkland. (Id.) As a result of these removals, Dr. Ashfaq suffered no salary reduction, as she continues to be employed as a professor of pathology at UTSW. (See id. at ¶ 8.)

Displeased with this result, Dr. Ashfaq insists that her removal from her appointments was wrongful. To this end, she points to the MSA, alleging that section 2.5 outlines procedures that must be followed before a UTSW physician can be removed from a position at Parkland. (Id. at ¶¶ 39-41.) These procedures allegedly require Parkland to provide written notice of its dissatisfaction with a particular physician. (Id. at ¶ 39.) UTSW and Parkland are then to attempt and resolve any differences to the satisfaction of both parties. (Id.) In contrast, Dr. Ashfaq avers, her removal was arbitrary and unilateral. (Id.)

On July 18, 2008, Dr. Ashfaq filed this action praying for damages for the alleged violation of her civil rights under 42 U.S.C. § 1983, maintaining that her removal deprived her of a constitutionally protected property interest without due process in violation of the Fourteenth Amendment of the United States Constitution. (Id. at ¶¶ 47-8.) Dr. Ashfaq also raises claims for intentional infliction of emotional distress, (Id. at ¶¶ 66-9), tortious interference, (Id. at 70-2), and defamation arising out of statements contained in Dr. Anderson’s letter, (Id. at 58-65). In response, Dr. *940 Anderson filed the instant motion to dismiss, claiming he is entitled to qualified immunity. (Def.’s Mot. to Dismiss.) Dr. Anderson’s motion is ripe, and the Court now turns to the merits of its decision.

II.

ANALYSIS

A. Legal Standard

The Federal Rules of Civil Procedure provide for the dismissal of an action, upon motion of the defendant, when a plaintiffs complaint fails “to state a claim upon which relief can be granted.” Fed. R.Civ.P. 12(b)(6).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Morris v. Dearborne
181 F.3d 657 (Fifth Circuit, 1999)
Southwestern Bell Telephone, LP v. City of Houston
529 F.3d 257 (Fifth Circuit, 2008)
Board of Regents of State Colleges v. Roth
408 U.S. 564 (Supreme Court, 1972)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Jett v. Dallas Independent School District
491 U.S. 701 (Supreme Court, 1989)
Wilson v. Layne
526 U.S. 603 (Supreme Court, 1999)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Russell L. Streetman v. Lt. Gary Jordan, Etc.
918 F.2d 555 (Fifth Circuit, 1991)
Jimmy Blackburn v. Marshall City Of
42 F.3d 925 (Fifth Circuit, 1995)
Raju v. Rhodes
809 F. Supp. 1229 (S.D. Mississippi, 1992)
Montgomery County Hospital District v. Brown
965 S.W.2d 501 (Texas Supreme Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
603 F. Supp. 2d 936, 2009 U.S. Dist. LEXIS 25243, 2009 WL 736074, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ashfaq-v-anderson-txnd-2009.